2023-11-012024-10-312024-10-31false04896520THE VILLAGE CLINIC LIMITED2025-07-07falseiso4217:GBPxbrli:pure048965202023-11-01048965202024-10-31048965202023-11-012024-10-31048965202022-11-01048965202023-10-31048965202022-11-012023-10-3104896520bus:SmallEntities2023-11-012024-10-3104896520bus:AuditExempt-NoAccountantsReport2023-11-012024-10-3104896520bus:FullAccounts2023-11-012024-10-3104896520bus:PrivateLimitedCompanyLtd2023-11-012024-10-3104896520core:WithinOneYear2024-10-3104896520core:AfterOneYear2024-10-3104896520core:WithinOneYear2023-10-3104896520core:AfterOneYear2023-10-3104896520core:ShareCapital2024-10-3104896520core:SharePremium2024-10-3104896520core:RevaluationReserve2024-10-3104896520core:OtherReservesSubtotal2024-10-3104896520core:RetainedEarningsAccumulatedLosses2024-10-3104896520core:ShareCapital2023-10-3104896520core:SharePremium2023-10-3104896520core:RevaluationReserve2023-10-3104896520core:OtherReservesSubtotal2023-10-3104896520core:RetainedEarningsAccumulatedLosses2023-10-3104896520core:LandBuildings2024-10-3104896520core:PlantMachinery2024-10-3104896520core:Vehicles2024-10-3104896520core:FurnitureFittings2024-10-3104896520core:OfficeEquipment2024-10-3104896520core:NetGoodwill2024-10-3104896520core:IntangibleAssetsOtherThanGoodwill2024-10-3104896520core:ListedExchangeTraded2024-10-3104896520core:UnlistedNon-exchangeTraded2024-10-3104896520core:LandBuildings2023-10-3104896520core:PlantMachinery2023-10-3104896520core:Vehicles2023-10-3104896520core:FurnitureFittings2023-10-3104896520core:OfficeEquipment2023-10-3104896520core:NetGoodwill2023-10-3104896520core:IntangibleAssetsOtherThanGoodwill2023-10-3104896520core:ListedExchangeTraded2023-10-3104896520core:UnlistedNon-exchangeTraded2023-10-3104896520core:LandBuildings2023-11-012024-10-3104896520core:PlantMachinery2023-11-012024-10-3104896520core:Vehicles2023-11-012024-10-3104896520core:FurnitureFittings2023-11-012024-10-3104896520core:OfficeEquipment2023-11-012024-10-3104896520core:NetGoodwill2023-11-012024-10-3104896520core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3104896520core:ListedExchangeTraded2023-11-012024-10-3104896520core:UnlistedNon-exchangeTraded2023-11-012024-10-3104896520core:MoreThanFiveYears2023-11-012024-10-3104896520core:Non-currentFinancialInstruments2024-10-3104896520core:Non-currentFinancialInstruments2023-10-3104896520dpl:CostSales2023-11-012024-10-3104896520dpl:DistributionCosts2023-11-012024-10-3104896520core:LandBuildings2023-11-012024-10-3104896520core:PlantMachinery2023-11-012024-10-3104896520core:Vehicles2023-11-012024-10-3104896520core:FurnitureFittings2023-11-012024-10-3104896520core:OfficeEquipment2023-11-012024-10-3104896520dpl:AdministrativeExpenses2023-11-012024-10-3104896520core:NetGoodwill2023-11-012024-10-3104896520core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3104896520dpl:GroupUndertakings2023-11-012024-10-3104896520dpl:ParticipatingInterests2023-11-012024-10-3104896520dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3104896520core:ListedExchangeTraded2023-11-012024-10-3104896520dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3104896520core:UnlistedNon-exchangeTraded2023-11-012024-10-3104896520dpl:CostSales2022-11-012023-10-3104896520dpl:DistributionCosts2022-11-012023-10-3104896520core:LandBuildings2022-11-012023-10-3104896520core:PlantMachinery2022-11-012023-10-3104896520core:Vehicles2022-11-012023-10-3104896520core:FurnitureFittings2022-11-012023-10-3104896520core:OfficeEquipment2022-11-012023-10-3104896520dpl:AdministrativeExpenses2022-11-012023-10-3104896520core:NetGoodwill2022-11-012023-10-3104896520core:IntangibleAssetsOtherThanGoodwill2022-11-012023-10-3104896520dpl:GroupUndertakings2022-11-012023-10-3104896520dpl:ParticipatingInterests2022-11-012023-10-3104896520dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012023-10-3104896520core:ListedExchangeTraded2022-11-012023-10-3104896520dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012023-10-3104896520core:UnlistedNon-exchangeTraded2022-11-012023-10-3104896520core:NetGoodwill2024-10-3104896520core:IntangibleAssetsOtherThanGoodwill2024-10-3104896520core:LandBuildings2024-10-3104896520core:PlantMachinery2024-10-3104896520core:Vehicles2024-10-3104896520core:FurnitureFittings2024-10-3104896520core:OfficeEquipment2024-10-3104896520core:AfterOneYear2024-10-3104896520core:WithinOneYear2024-10-3104896520core:ListedExchangeTraded2024-10-3104896520core:UnlistedNon-exchangeTraded2024-10-3104896520core:ShareCapital2024-10-3104896520core:SharePremium2024-10-3104896520core:RevaluationReserve2024-10-3104896520core:OtherReservesSubtotal2024-10-3104896520core:RetainedEarningsAccumulatedLosses2024-10-3104896520core:NetGoodwill2023-10-3104896520core:IntangibleAssetsOtherThanGoodwill2023-10-3104896520core:LandBuildings2023-10-3104896520core:PlantMachinery2023-10-3104896520core:Vehicles2023-10-3104896520core:FurnitureFittings2023-10-3104896520core:OfficeEquipment2023-10-3104896520core:AfterOneYear2023-10-3104896520core:WithinOneYear2023-10-3104896520core:ListedExchangeTraded2023-10-3104896520core:UnlistedNon-exchangeTraded2023-10-3104896520core:ShareCapital2023-10-3104896520core:SharePremium2023-10-3104896520core:RevaluationReserve2023-10-3104896520core:OtherReservesSubtotal2023-10-3104896520core:RetainedEarningsAccumulatedLosses2023-10-3104896520core:NetGoodwill2022-11-0104896520core:IntangibleAssetsOtherThanGoodwill2022-11-0104896520core:LandBuildings2022-11-0104896520core:PlantMachinery2022-11-0104896520core:Vehicles2022-11-0104896520core:FurnitureFittings2022-11-0104896520core:OfficeEquipment2022-11-0104896520core:AfterOneYear2022-11-0104896520core:WithinOneYear2022-11-0104896520core:ListedExchangeTraded2022-11-0104896520core:UnlistedNon-exchangeTraded2022-11-0104896520core:ShareCapital2022-11-0104896520core:SharePremium2022-11-0104896520core:RevaluationReserve2022-11-0104896520core:OtherReservesSubtotal2022-11-0104896520core:RetainedEarningsAccumulatedLosses2022-11-0104896520core:AfterOneYear2023-11-012024-10-3104896520core:WithinOneYear2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:CostValuation2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-012024-10-3104896520core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3104896520core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3104896520core:Non-currentFinancialInstrumentscore:CostValuation2023-10-3104896520core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-3104896520core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-3104896520core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-3104896520core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-3104896520core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-3104896520core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-3104896520core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-3104896520core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-3104896520bus:Director12023-11-012024-10-3104896520bus:Director22023-11-012024-10-3104896520core:FurnitureFittingsToolsEquipment2023-10-3104896520core:FurnitureFittingsToolsEquipment2023-11-012024-10-3104896520core:FurnitureFittingsToolsEquipment2024-10-31

THE VILLAGE CLINIC LIMITED

Registered Number
04896520
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2024

THE VILLAGE CLINIC LIMITED
Company Information
for the year from 1 November 2023 to 31 October 2024

Directors

ALBUTT, Sally Dawn
DONNELLY, Lucy Jane

Company Secretary

ALBUTT, Sally Dawn

Registered Address

11 Tarlings Yard
Church Road, Bishops Cleeve
Cheltenham
GL52 8RN

Registered Number

04896520 (England and Wales)
THE VILLAGE CLINIC LIMITED
Balance Sheet as at
31 October 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets426,65827,860
26,65827,860
Current assets
Stocks58,4078,952
Debtors10,82810,241
Cash at bank and on hand78,93586,320
98,170105,513
Creditors amounts falling due within one year6(23,802)(23,986)
Net current assets (liabilities)74,36881,527
Total assets less current liabilities101,026109,387
Creditors amounts falling due after one year7(42,651)(49,259)
Net assets58,37560,128
Capital and reserves
Called up share capital22
Profit and loss account58,37360,126
Shareholders' funds58,37560,128
The financial statements were approved and authorised for issue by the Board of Directors on 7 July 2025, and are signed on its behalf by:
DONNELLY, Lucy Jane
Director
Registered Company No. 04896520
THE VILLAGE CLINIC LIMITED
Notes to the Financial Statements
for the year ended 31 October 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measure at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Plant and machinery3
Fixtures and fittings5
Office Equipment3
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year1717
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 November 2340,00040,000
At 31 October 2440,00040,000
Amortisation and impairment
At 01 November 2340,00040,000
At 31 October 2440,00040,000
Net book value
At 31 October 24--
At 31 October 23--
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 November 2333,39617,4819,53160,408
Additions1,0347,4891,2589,781
Disposals--(2,224)(2,224)
At 31 October 2434,43024,9708,56567,965
Depreciation and impairment
At 01 November 2313,66210,3208,56632,548
Charge for year7,8982,21387210,983
On disposals--(2,224)(2,224)
At 31 October 2421,56012,5337,21441,307
Net book value
At 31 October 2412,87012,4371,35126,658
At 31 October 2319,7347,16196527,860
5.Stocks

2024

2023

££
Raw materials and consumables8,4078,952
Total8,4078,952
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables1,132841
Taxation and social security9,59210,920
Other creditors11,1589,640
Accrued liabilities and deferred income1,9202,585
Total23,80223,986
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts42,65149,259
Total42,65149,259